NasdaqGS:HALOBiotechs
Is Halozyme (HALO) Elevating Drug Delivery Leadership to Reframe Its Core Investment Narrative?
Halozyme Therapeutics, Inc. has appointed David Ramsay as President Drug Delivery, effective June 30, 2026, giving him an enterprise-wide mandate to drive the company’s drug delivery technologies and report directly to CEO Helen Torley.
This newly created role, filled by a long-tenured former Halozyme executive with deep financial and commercialization experience, points to an intensified focus on scaling the firm’s drug delivery partnerships and alliances.
We’ll now examine how creating an...